Detailed information for compound 284277

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 264.234 | Formula: C12H12N2O5
  • H donors: 2 H acceptors: 3 LogP: 0.37 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cccc(c1C1OC(=O)NC1=O)NC(=O)C
  • InChi: 1S/C12H12N2O5/c1-6(15)13-7-4-3-5-8(18-2)9(7)10-11(16)14-12(17)19-10/h3-5,10H,1-2H3,(H,13,15)(H,14,16,17)
  • InChiKey: IAHWQCIGWCMWQB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis cyclin B, putative 0.0107 0.295 1
Loa Loa (eye worm) cyclin domain-containing protein 0.0261 1 1
Trichomonas vaginalis cyclin B, putative 0.0107 0.295 1
Echinococcus multilocularis cyclin b3 0.0107 0.295 0.4358
Trichomonas vaginalis cyclin D, putative 0.0107 0.295 1
Entamoeba histolytica cyclin, putative 0.0107 0.295 1
Brugia malayi Cyclin, N-terminal domain containing protein 0.0107 0.295 0.295
Trichomonas vaginalis cyclins, putative 0.0107 0.295 1
Echinococcus multilocularis jun protein 0.0191 0.677 1
Plasmodium falciparum cyclin 0.0107 0.295 1
Trichomonas vaginalis cyclins, putative 0.0107 0.295 1
Echinococcus granulosus cyclins 0.0107 0.295 0.4358
Trichomonas vaginalis cyclin B, putative 0.0107 0.295 1
Trichomonas vaginalis cyclin A, putative 0.0107 0.295 1
Schistosoma mansoni cyclin B3 0.0107 0.295 0.5748
Echinococcus multilocularis cyclins 0.0107 0.295 0.4358
Trypanosoma brucei mitotic cyclin 6 0.0107 0.295 1
Plasmodium vivax protein kinase Crk2 0.0043 0 0.5
Echinococcus multilocularis cyclins 0.0107 0.295 0.4358
Echinococcus multilocularis cyclins 0.0107 0.295 0.4358
Brugia malayi Cyclin, N-terminal domain containing protein 0.0107 0.295 0.295
Echinococcus multilocularis cyclins 0.0107 0.295 0.4358
Echinococcus granulosus cyclins 0.0107 0.295 0.4358
Echinococcus multilocularis G2:mitotic specific cyclin B3 0.0107 0.295 0.4358
Trichomonas vaginalis cyclins, putative 0.0107 0.295 1
Leishmania major cyclin 0.0107 0.295 1
Echinococcus granulosus cyclin B3 1 0.0107 0.295 0.4358
Trypanosoma cruzi cyclin 6, putative 0.0107 0.295 1
Echinococcus multilocularis cyclin B3 1 0.0107 0.295 0.4358
Loa Loa (eye worm) cyclin domain-containing protein 0.0107 0.295 0.295
Echinococcus granulosus G2:mitotic specific cyclin B3 0.0107 0.295 0.4358
Brugia malayi Cyclin, N-terminal domain containing protein 0.0107 0.295 0.295
Echinococcus granulosus cyclins 0.0107 0.295 0.4358
Echinococcus granulosus Basic leucine zipper bZIP transcription factor 0.0191 0.677 1
Trichomonas vaginalis conserved hypothetical protein 0.0107 0.295 1
Trichomonas vaginalis cyclin D, putative 0.0107 0.295 1
Schistosoma mansoni jun-related protein 0.0155 0.5133 1
Brugia malayi bZIP transcription factor family protein 0.0191 0.677 0.677
Trichomonas vaginalis cyclins, putative 0.0107 0.295 1
Entamoeba histolytica cyclin, putative 0.0107 0.295 1
Trypanosoma cruzi cyclin, putative 0.0107 0.295 1
Echinococcus granulosus jun protein 0.0191 0.677 1
Echinococcus granulosus cyclins 0.0107 0.295 0.4358
Giardia lamblia Cyclin A 0.0107 0.295 1
Brugia malayi hypothetical protein 0.015 0.4893 0.4893
Schistosoma mansoni cyclins 0.0107 0.295 0.5748
Entamoeba histolytica cyclin family protein 0.0107 0.295 1
Trichomonas vaginalis cyclins, putative 0.0107 0.295 1
Echinococcus multilocularis cyclins 0.0107 0.295 0.4358
Leishmania major CYC2-like cyclin, putative,cyclin 6, putative 0.0107 0.295 1
Echinococcus multilocularis cyclin B 0.0107 0.295 0.4358
Loa Loa (eye worm) hypothetical protein 0.0107 0.295 0.295
Entamoeba histolytica cyclin family protein 0.0107 0.295 1
Trichomonas vaginalis cyclin B3, putative 0.0107 0.295 1
Giardia lamblia G2/mitotic-specific cyclin B 0.0107 0.295 1
Schistosoma mansoni hypothetical protein 0.0155 0.5133 1
Trichomonas vaginalis cyclin B, putative 0.0107 0.295 1
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription factor 0.0191 0.677 1
Echinococcus granulosus cyclins 0.0107 0.295 0.4358
Echinococcus granulosus cyclin b3 0.0107 0.295 0.4358
Trypanosoma cruzi CYC2-like cyclin, putative 0.0107 0.295 1
Echinococcus multilocularis cyclins 0.0107 0.295 0.4358
Loa Loa (eye worm) hypothetical protein 0.0107 0.295 0.295
Echinococcus granulosus cyclin B 0.0107 0.295 0.4358
Trichomonas vaginalis cyclin B, putative 0.0107 0.295 1
Loa Loa (eye worm) hypothetical protein 0.0185 0.6531 0.6531
Trypanosoma cruzi cyclin, putative 0.0107 0.295 1
Giardia lamblia Hypothetical protein 0.0107 0.295 1
Toxoplasma gondii hypothetical protein 0.0081 0.1763 1
Echinococcus multilocularis cyclins 0.0107 0.295 0.4358
Onchocerca volvulus 0.015 0.4893 1
Schistosoma mansoni cyclin B 0.0107 0.295 0.5748

Activities

Activity type Activity value Assay description Source Reference
Blood sugar lowering (functional) 0 % Ability to lower blood sugar level at the dose of 25 mg/kg in fasted rats, by using glucose tolerance test(GTT); NA=Inactive ChEMBL. 3701788

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.